Study assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.
Christopher R. Frei, PharmD, MSc, BCPS
Advertisement
Articles by Christopher R. Frei, PharmD, MSc, BCPS
Advertisement
Latest Updated Articles
- Patterns of Specific Testing for Patients With Chronic Myelogenous Leukemia
Published: February 12th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Blenrep Receives FDA Approval for Treatment of Relapsed or Refractory Multiple Myeloma
2
Two Doses of PCV20 in Lymphoma Survivors Elicits Greater Humoral Response
3
Addressing Burnout in Pharmacy Residency: A Comprehensive Approach to Enhancing Well-Being
4
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials
5
